Dr. Riley Kirk is a cannabis research scientist and educator. She obtained her Ph.D. in pharmaceutical sciences, specializing in natural product chemistry, studying the traditional and contemporary uses of hundreds of medicinal plants. She is currently an assistant associate professor at the University of Rhode Island, has worked as an immunology scientist in the biotech industry, and works in the cannabis industry studying the chemical complexity of cannabis smoke.
Riley is also the co-founder of the cannabis research and education non-profit organization called the Network of Applied Pharmacognosy (NAP). Through NAP and on her podcast, Riley uses science as advocacy to research and communicate findings that highlight the unique power of natural products. The goal of Riley’s work is to unite people in the Cannabis industry, academia, and consumers to further the reach of Cannabis education and reduce harm.
Riley is passionate about making Cannabis science accessible through social media channels and alternative media which lead to Bioactive; an educational podcast which disseminates the chemistry and pharmacology of natural products. On this bi-weekly podcast, she covers current news and research surrounding cannabis, psychedelics, toxins, pharmaceuticals & other bioactive substances. Listen for special guests highlighting community stories.
All content for BIOACTIVE is the property of Riley D. Kirk, Ph.D. and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dr. Riley Kirk is a cannabis research scientist and educator. She obtained her Ph.D. in pharmaceutical sciences, specializing in natural product chemistry, studying the traditional and contemporary uses of hundreds of medicinal plants. She is currently an assistant associate professor at the University of Rhode Island, has worked as an immunology scientist in the biotech industry, and works in the cannabis industry studying the chemical complexity of cannabis smoke.
Riley is also the co-founder of the cannabis research and education non-profit organization called the Network of Applied Pharmacognosy (NAP). Through NAP and on her podcast, Riley uses science as advocacy to research and communicate findings that highlight the unique power of natural products. The goal of Riley’s work is to unite people in the Cannabis industry, academia, and consumers to further the reach of Cannabis education and reduce harm.
Riley is passionate about making Cannabis science accessible through social media channels and alternative media which lead to Bioactive; an educational podcast which disseminates the chemistry and pharmacology of natural products. On this bi-weekly podcast, she covers current news and research surrounding cannabis, psychedelics, toxins, pharmaceuticals & other bioactive substances. Listen for special guests highlighting community stories.
Understanding Cannabinoid Hyperemesis Syndrome (CHS) with Dr. Codi Peterson, & Megan Mbengue
BIOACTIVE
1 hour 8 minutes
5 months ago
Understanding Cannabinoid Hyperemesis Syndrome (CHS) with Dr. Codi Peterson, & Megan Mbengue
In this episode of the Bioactive Podcast, we dive deep into a lesser-known but serious condition known as Cannabinoid Hyperemesis Syndrome (CHS). Join host Dr. Riley Kirk and guests Dr. Codi Peterson and Megan Mbengue as they explore the paradox of CHS, where in some rare cases, regular cannabis use leads to severe nausea, vomiting, and abdominal pain, despite cannabis being commonly used for its anti-nausea properties.
We discuss the symptoms, the prodrome phase, and the potential genetic components that may predispose individuals to CHS. The episode also highlights an ongoing study being conducted by Dr. Kirk, Dr. Peterson and Megan Mbengue with the University of California, Irvine, aimed at understanding CHS better and improving diagnosis and treatment options.
Listeners will learn about the unique relief some patients find in hot showers and capsaicin cream, as well as the challenges healthcare professionals face in diagnosing this condition. We also touch on the importance of understanding the role of THC, CBD, and other cannabinoids in relation to CHS, and the implications for cannabis users.
Whether you're a cannabis consumer, a healthcare professional, or just curious about CHS, this episode provides valuable insights and encourages participation in the ongoing research to better understand this complex syndrome.
Links to the study and more resources are available in the show notes!
Don't forget to like, subscribe, and share your thoughts in the comments below!
Link to take part in the CHS Study:
https://uci.questionpro.com/CHS-P1
Join the Bioactive Patreon:
https://www.patreon.com/cannabichem
Learn more about your ad choices. Visit megaphone.fm/adchoices
BIOACTIVE
Dr. Riley Kirk is a cannabis research scientist and educator. She obtained her Ph.D. in pharmaceutical sciences, specializing in natural product chemistry, studying the traditional and contemporary uses of hundreds of medicinal plants. She is currently an assistant associate professor at the University of Rhode Island, has worked as an immunology scientist in the biotech industry, and works in the cannabis industry studying the chemical complexity of cannabis smoke.
Riley is also the co-founder of the cannabis research and education non-profit organization called the Network of Applied Pharmacognosy (NAP). Through NAP and on her podcast, Riley uses science as advocacy to research and communicate findings that highlight the unique power of natural products. The goal of Riley’s work is to unite people in the Cannabis industry, academia, and consumers to further the reach of Cannabis education and reduce harm.
Riley is passionate about making Cannabis science accessible through social media channels and alternative media which lead to Bioactive; an educational podcast which disseminates the chemistry and pharmacology of natural products. On this bi-weekly podcast, she covers current news and research surrounding cannabis, psychedelics, toxins, pharmaceuticals & other bioactive substances. Listen for special guests highlighting community stories.
